IRRAS Announces Changed Publication Date for the Q4 2022 Interim Report
Stockholm, Sweden, February 1, 2023 – IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that the publication of the interim report for the period from October to December 2022 (“Q4 2022 Interim Report”) will be published on Thursday, 16 February 2023. Report Previously Announced Date New DateQ4 2023 interim report 22 February 2023 16 February 2023 Financial calendar for 2023 Annual report 2022